Malaria is still a major health problem in most parts of the world and development of novel drugs or a vaccine is urgently needed. In malaria endemic areas, most children <3-4 years have a risk of developing severe malaria, whereas adults have acquired resistance to clinical disease. Recent studies have identified glycosyiphosphatidylinositol (GPI) anchors of P. falciparum as the toxins involved in malaria pathology. Parasite GPIs exert toxic effects by transducing signals leading to the expression of inflammatory cytokines and cell adhesion molecules, which initiate the process of pathogenesis. Since GPIs are pathogemcity factors the acquired immunity in adults must be related significantly to antibody response against GPIs. We recently found that adults in Western Kenya have high levels of parasite GPI-specific antibodies, whereas susceptible children and people not previously exposed to malaria parasite lack such an antibody response; the anti-GPI antibody response correlated with disease protection. Therefore, understanding of the structures, biologic activity, and immunologic properties of the parasite GPIs is likely to offer strategies for the development of novel therapeutics or a vaccine to prevent infection as well as pathogenesis. In this application we propose to study: (1) Study the levels of naturally elicited anti-GPI antibodies in people from different malaria endemic regions and in defined case control studies. 2) Chemically synthesize active parts of GPIs and total GPI structures. (2) Study the GPIs for inductionof proinflammatory responses in macrophages and in experimental animals, and investigate the antigenicity of GPIs. 3) Assess biological cytokine-inducing property of GPIs in macrophages and in experimental animals and their ability to bind anti-GPI antibodies in sera of immune people. (4) Immunize animals with GPIs to produce anti-GPI polyclonal and monoclonal antibodies. Study anti-sera or purified antibodies for neutralization of cytokine-inducing property of GPIs and investigate the ability of ant-GPI antibodies in providing protection against malaria pathogenesis. 5) Study GPIs for Toll-like receptor-mediated induction of TNF-a in macrophages. 6) Study inhibition of GPI biosynthesis using synthetic GPI intermediates and inhibitors of glycosyltransferases. The long-term objectives are to study the role of parasite GPIs in host interactions, and to exploit GPI structures for the development of anti-malarial drugs and a vaccine.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI041139-09
Application #
6881362
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Program Officer
Wali, Tonu M
Project Start
1998-01-15
Project End
2007-05-31
Budget Start
2005-05-01
Budget End
2007-05-31
Support Year
9
Fiscal Year
2005
Total Cost
$307,602
Indirect Cost
Name
Pennsylvania State University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
Wu, Xianzhu; Dayanand, Kiran K; Thylur, Ramesh P et al. (2017) Small molecule-based inhibition of MEK1/2 proteins dampens inflammatory responses to malaria, reduces parasite load, and mitigates pathogenic outcomes. J Biol Chem 292:13615-13634
Thylur, Ramesh P; Wu, Xianzhu; Gowda, Nagaraj M et al. (2017) CD36 receptor regulates malaria-induced immune responses primarily at early blood stage infection contributing to parasitemia control and resistance to mortality. J Biol Chem 292:9394-9408
Yao, Xiangyu; Wu, Jian; Lin, Meng et al. (2016) Increased CD40 Expression Enhances Early STING-Mediated Type I Interferon Response and Host Survival in a Rodent Malaria Model. PLoS Pathog 12:e1005930
Sadashiva, Maralinganadoddi P; Gowda, Raghavendra; Wu, Xianzhu et al. (2015) A non-cytotoxic N-dehydroabietylamine derivative with potent antimalarial activity. Exp Parasitol 155:68-73
Wu, Xianzhu; Gowda, Nagaraj M; Gowda, D Channe (2015) Phagosomal Acidification Prevents Macrophage Inflammatory Cytokine Production to Malaria, and Dendritic Cells Are the Major Source at the Early Stages of Infection: IMPLICATION FOR MALARIA PROTECTIVE IMMUNITY DEVELOPMENT. J Biol Chem 290:23135-47
Bhavanandan, Veer P; Gowda, D Channe (2014) Introduction to the complexity of cell surface and tissue matrix glycoconjugates. Adv Neurobiol 9:1-31
Gowda, Nagaraj M; Wu, Xianzhu; Kumar, Sanjeev et al. (2013) CD36 contributes to malaria parasite-induced pro-inflammatory cytokine production and NK and T cell activation by dendritic cells. PLoS One 8:e77604
Zhu, Xiaotong; Pan, Yanyan; Li, Ying et al. (2012) Targeting Toll-like receptors by chloroquine protects mice from experimental cerebral malaria. Int Immunopharmacol 13:392-7
Zhu, Jianzhong; Weinberg, Rebecca; Wu, Xianzhu et al. (2012) I?b-? plays an important role in the ERK-dependent dysregulation of malaria parasite GPI-induced IL-12 expression. IUBMB Life 64:187-93
Gowda, Nagaraj M; Wu, Xianzhu; Gowda, D Channe (2012) TLR9 and MyD88 are crucial for the development of protective immunity to malaria. J Immunol 188:5073-85

Showing the most recent 10 out of 28 publications